<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02685891</url>
  </required_header>
  <id_info>
    <org_study_id>PB_2016-00254</org_study_id>
    <nct_id>NCT02685891</nct_id>
  </id_info>
  <brief_title>Brain Maturation and Sleep</brief_title>
  <acronym>BMS</acronym>
  <official_title>Exploring Diurnal Changes in Markers of Cortical Plasticity Using Multimodal Imaging in Healthy Children, Adolescents and Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Children's Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigator evaluates whether there are age-specific diurnal changes in&#xD;
      markers of cortical plasticity in children, adolescents and adults. The question will be&#xD;
      investigated by the quantification of brain metabolites and structural brain volumes using&#xD;
      magnet resonance imaging (MRI) and electrophysiological markers using sleep encephalography&#xD;
      (sleep EEG). In a second step, it will be tested how these markers of cortical plasticity&#xD;
      change depending on a modulation of sleep by applying tones during deep sleep.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Given that children and adolescents undergo entirely different maturational processes&#xD;
      (children show an increase, adolescents a decrease in synapse density) larger diurnal changes&#xD;
      in children are expected compared to adolescents concerning brain metabolites and structural&#xD;
      markers. These cortical changes in synapse density are thought to be reflected in&#xD;
      electrophysiological markers in the sleep EEG (children show a higher slow wave activity,&#xD;
      adolescents a reduced slow wave activity). With the modulation of the deep (slow wave) sleep&#xD;
      by playing short, low volume tones, the investigators want to test if there is a causal&#xD;
      relationship between slow wave sleep and markers of cortical plasticity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diurnal changes in brain metabolites</measure>
    <time_frame>3 years</time_frame>
    <description>concentration of brain metabolites measured by MR spectroscopy change from evening to morning</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>electrophysiological markers change in dependance of the diurnal variation of brain metabolites</measure>
    <time_frame>3 years</time_frame>
    <description>electrophysiological markers (sleep EEG) change in dependance of the diurnal variation of brain metabolites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>structural markers change in dependance of the diurnal variation of brain metabolites</measure>
    <time_frame>3 years</time_frame>
    <description>structural markers (MR volumes) change in dependance of the diurnal variation of brain metabolites</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>playing tones</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During slow-wave sleep short tones (50ms, 50dB) will be played</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Playing no tones</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>During slow-wave sleep no tones will be played</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Playing tones during deep sleep</intervention_name>
    <description>Playing tones time locked to slow waves (Duration:50ms, volume: 50dB)</description>
    <arm_group_label>playing tones</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham condition</intervention_name>
    <description>in the sham condition, no tones will be played</description>
    <arm_group_label>Playing no tones</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female subjects 8 to 30 years of age,&#xD;
&#xD;
          -  good general health Status&#xD;
&#xD;
          -  right-handedness,&#xD;
&#xD;
          -  Written informed consent after participants' information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  sleep disorders (insomnia, sleep disordered breathing, restless legs syndrome)&#xD;
&#xD;
          -  sleep complaints in general&#xD;
&#xD;
          -  irregular sleep-wake rhythm&#xD;
&#xD;
          -  daytime sleep&#xD;
&#xD;
          -  travelling across a time zone within the last month&#xD;
&#xD;
          -  diseases or lesions of the central nervous system&#xD;
&#xD;
          -  psychiatric diseases&#xD;
&#xD;
          -  learning disability&#xD;
&#xD;
          -  skin allergy or very sensitive skin&#xD;
&#xD;
          -  acute pediatric disease&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  drug and medication use and abuse&#xD;
&#xD;
          -  nicotine use&#xD;
&#xD;
          -  high caffeine consumption (&gt;2 servings/day (&gt;160 mg caffeine); including coffee, tea,&#xD;
             white and dark chocolate, coca cola, energy drink)&#xD;
&#xD;
          -  Alcohol consumption in children and adolescents under 16 years&#xD;
&#xD;
          -  high alcohol consumption in adults (&gt; 1 standard serving/day (&gt;14 mg Alcohol))&#xD;
&#xD;
          -  high alcohol consumption in adolescents aged 16 years and above (&gt; 3-4 Standard&#xD;
             servings per week)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carina Volk</last_name>
    <phone>+41 44 266 8186</phone>
    <email>carina.volk@kispi.uzh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Children's Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carina Volk</last_name>
      <phone>+41 44 266 8186</phone>
      <email>carina.volk@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Reto Huber</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>February 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2016</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

